In the present study, we focused on the potential utility of droplet digital polymerase chain reaction (ddPCR) in detecting c-MYC GCN gain in tumor tissue and cell-free plasma of CRC patients, as a prognostic marker. The gene discussed is MYC; the disease is neoplasm.